T S B Møller
Adaptive responses to cefotaxime treatment in ESBL-producing Escherichia coli and the possible use of significantly regulated pathways as novel secondary targets
Møller, T S B; Rau, M H; Bonde, C S; Sommer, M O A; Guardabassi, L; Olsen, J E
Authors
M H Rau
C S Bonde
M O A Sommer
L Guardabassi
J E Olsen
Abstract
The aim of the study was to determine how ESBL-producing Escherichia coli change the expression of metabolic and biosynthesis genes when adapting to inhibitory concentrations of cefotaxime. Secondly, it was investigated whether significantly regulated pathways constitute putative secondary targets that can be used to combat the resistant bacteria.
Citation
Møller, T. S. B., Rau, M. H., Bonde, C. S., Sommer, M. O. A., Guardabassi, L., & Olsen, J. E. (in press). Adaptive responses to cefotaxime treatment in ESBL-producing Escherichia coli and the possible use of significantly regulated pathways as novel secondary targets. Journal of Antimicrobial Chemotherapy, 71(9), 2449-2459. https://doi.org/10.1093/jac/dkw198
Journal Article Type | Article |
---|---|
Acceptance Date | Apr 26, 2016 |
Deposit Date | Sep 5, 2018 |
Journal | Journal of Antimicrobial Chemotherapy |
Print ISSN | 0305-7453 |
Publisher | Oxford University Press |
Peer Reviewed | Peer Reviewed |
Volume | 71 |
Issue | 9 |
Pages | 2449-2459 |
DOI | https://doi.org/10.1093/jac/dkw198 |
Public URL | https://rvc-repository.worktribe.com/output/1396865 |